Posted by gladiator > 1 month ago | Report Abuse

Genting RM5 from resistant to support.

Posted by keyman > 1 month ago | Report Abuse

Jtiasa... This rubbish stock trapped me for years... One of the boss this company also calls A thai... A real rubbish...

Posted by Ytl2023 > 1 month ago | Report Abuse

Profit from jtiasa. Sudah overtake my profit from ytlp or ytl. U wrong timing

Posted by Ytl2023 > 1 month ago | Report Abuse

Genting. Buy sell buy sell. Can sell some profit. Hold sure mati long time ago

Posted by stampid54 > 1 month ago | Report Abuse

looks like many traders took profit at above 5.10

Posted by Goldgent > 1 month ago | Report Abuse

All comrades should be on board already.
Who else missed the boat?

Posted by Save > 1 month ago | Report Abuse

I am wrong again, mother lead son.....
(Today Son move mother?)

Posted by smurfbee > 1 month ago | Report Abuse

$5.58 coming.... brace for bull run shortly....

Posted by Peaches L > 1 month ago | Report Abuse

All comrades shud strive to reap GenB’s maximum value as a reward for their loyalty in LKT’s leadership.

Posted by choysun > 1 month ago | Report Abuse

Wah, today a lot of washing also. Witching in 2 days. Which way will it trend. :)

Posted by EngineeringProfit > 1 month ago | Report Abuse

UP

Posted by newbie2019 > 1 month ago | Report Abuse

witching day up to 5.3… sell 3% I will

Posted by Save > 1 month ago | Report Abuse

Uptrend declined. RM5 support still effective.......let stay a few day at 5

Posted by AngTayKor > 1 month ago | Report Abuse

Posted by newbie2019 > 24 minutes ago | Report Abuse
witching day up to 5.3… sell 3% I will
-----------------

May huge match down also.

Posted by Michael_chan2022 > 1 month ago | Report Abuse

https://www.bloomberg.com/news/articles/2024-03-13/passenger-traffic-at-changi-airport-rebounds-to-pre-covid-levels?embedded-checkout=true
Singapore's Changi Passenger Numbers Hit Pre-Covid Levels for the First Time

Jiayu... Go ..go GenB

Posted by newbie2019 > 1 month ago | Report Abuse

scary leh…ATK

Posted by choysun > 1 month ago | Report Abuse

Can put lower buy on witching to see if can get discount :)

Posted by Goldgent > 1 month ago | Report Abuse

Witching? Only a handful GLC counters celebrate,
Seldom see Uncle Lim counters celebrate in the past five years.

Posted by AngTayKor > 1 month ago | Report Abuse

Got la. I ever saw last moment kena ram n matched up 20 sen. Also saw before huge matched down 10 sen.

Posted by Goldgent > 1 month ago | Report Abuse

You're right. Checked 2023 and found on Q2
17/3/23 open 4.56 close 4.56
16/6/23 open 4.15 close 4.35
15/9/23 open 4.22 close 4.20
15/12/23 open 4.72 close 4.70

Posted by AngTayKor > 1 month ago | Report Abuse

Besides quadruple witching days, there were some strange days the closing price can match up or down by over 10 sen! Could be option expiry or something

Posted by Michael_chan2022 > 1 month ago | Report Abuse

From 4 to RM5 in less than 6 months.., it is the Top performing recovery stock of 2024. Don't miss it!

Posted by EngineeringProfit > 1 month ago | Report Abuse

The key driver for KLSe 1420 to 1520 too

Posted by EngineeringProfit > 1 month ago | Report Abuse

Parking 1 mil here- no fears

Posted by Michael_chan2022 > 1 month ago | Report Abuse

Yes, buy more GenB shares...if you can afford it. Looking forward to Q2 and Q3 when GenB reports its financial result and ang mohs is expected to cut interest rate in June

Posted by Michael_chan2022 > 1 month ago | Report Abuse

https://www.klsescreener.com/v2/news/view/1293281/%E7%BE%8E%E8%82%A1%E6%B3%A1%E6%B2%AB%E9%80%90%E6%B8%90%E6%89%A9%E5%A4%A7-%E9%A9%AC%E8%82%A1%E6%88%90%E5%A4%96%E8%B5%84%E9%81%BF%E9%A3%8E%E6%B8%AF
美股泡沫逐渐扩大 马股成外资避风港

看到嗎？GenM也是避风港之一

Posted by keyman > 1 month ago | Report Abuse

I am a poor oldie... I dunt have 1 mil... 800K.... lah... SHOW HAND🤭

Posted by Michael_chan2022 > 1 month ago | Report Abuse

2024, 一起發..

Posted by keyman > 1 month ago | Report Abuse

I dun wish to huat... Dont bring oldie masuk longkang yah🤭

Posted by EngineeringProfit > 1 month ago | Report Abuse

KLSE cannot reach 1660 by year end without Genting!! Cheers!! Let's show hand

Posted by Michael_chan2022 > 1 month ago | Report Abuse

買在RM4+, why worry about masuk longkang..

Posted by Save > 1 month ago | Report Abuse

Bull Bear struggling at 5.00. Who may win in March? I am not optimistic today because KLCI 1555 double tops shadow ..........but will close eye and hold till May 1st Q results to decide.

Posted by Save > 1 month ago | Report Abuse

GENP today ex 13 sen dividend will contribute to Genting coffer on 2-April

Posted by neohts > 1 month ago | Report Abuse

GenP and GenM dividend will contribute to GenB CASH on hand.

Posted by neohts > 1 month ago | Report Abuse

Just hold or buy more. No need to do anything. Just wait for TauRX. Heng Ah, Ong Ah, Huat Ah.

Posted by MG9231 > 1 month ago | Report Abuse

Uobkayhian latest report on Genting
Genting (GENT MK)

TauRx’s Positive Discovery A Potential Wild Card
TauRx’s convincing 24-month Phase 3 clinical trial data for its Alzheimer’s HMTM drug
may be the missing puzzle piece for regulatory approval, and could eventually unlock
deep value in GENT’s investment. On hindsight, the procedure for HTMTM securing
approval and commercial rollout may be lengthy. That said, even without the TauRx
factor, GENT trades at a cheap valuation with plenty of re-rating catalysts, Maintain
BUY with a higher target price of RM6.13 as we partially impute TauRx’s option value.

Posted by MG9231 > 1 month ago | Report Abuse

TauRx is a wild card for GENT, if commercialisation materialises. If TauRx secures
approval from key regulators and its HMTM drugs are commercially rolled out, the group
may be re-looking at an IPO. To recall, TauRx was initially eyeing a Nasdaq IPO in 2017
(with a potential valuation of US$15b), according to Wall Street Journal in Dec 15. If so, we
acknowledge that GENT’s 20.3% stake in TauRx could be translated to RM3.54/share
(e.RM4.50/US$1) or c.71% of its current market cap.
• Downside fairly limited if TauRx remains in limbo or does not work out. Even without
the TauRx factor, GENT’s investment merits remain appealing as the group is on track to
chart above pre-pandemic earnings dynamic in 2024-25, based on the booming tourism
scene and plenty of event catalysts from subsidiaries GENM and GENS. Furthermore, as
GENT’s valuations remain significantly below pre-pandemic levels with undervalued financial
matrixes, the group may not encounter a steep selldown in a scenario that TauRx
disappoints.

Posted by MG9231 > 1 month ago | Report Abuse

- For the US, a New Drug Application (NDA) will be submitted to the Food and Drug
Administration (FDA) to review. Normally, the FDA is allotted 10 months to review new
drugs, while under priority review, that time is shortened to six months. - For the UK, we expect TauRx to seek approval via the Innovative Licencing and Access
Pathway (ILAP). Recall that in 2022, TauRx received an innovation passport from the UK’s
regulatory agency MHRA.The Innovation Passport is the first stage of the Innovative
Licensing and Access Pathway (ILAP). After attending an ILAP meeting within 4-6 weeks
of application, opinion will be received within another four weeks. - For other regions, we understand that TauRx’s subsidiary – Poredeen Limited – has
appointed and given ICB Medical the exclusive rights to manage the importation and
logistics for the HMTM drugs in Hong Kong and Macau, where qualified prescribing
doctors can request HMTM drugs on behalf of eligible patients. However, HMTM drugs are
not commercially sold there yet. Poredeen will also be meeting and submitting data
packages to other drug regulators in more territories, including China.

Posted by MG9231 > 1 month ago | Report Abuse

VALUATION/RECOMMENDATION
• As TauRx is approaching a new milestone with potential commercialisation in future,
we now impute a 10% option value of TauRx’s initial IPO valuations of US$15b into our
target price, which translates into 35 sen/share. We deem this reasonable as TauRx is
submitting HMTM for regulatory approval soon.
• Maintain BUY with higher target price of RM6.13 (from RM5.78), which implies 6.5x
2024F EV/EBITDA and 0.7x 2024F P/B. In a blue-sky scenario, target price will be RM9.32 if
we fully factor in TauRx’s potential monetisation value.

Posted by Michael_chan2022 > 1 month ago | Report Abuse

Buy 500,000 GenB shares today at RM5 each and sell them at Rm10. Then, consider switching over to Public Bank, where you can buy 1 million shares... it is still possible.

Lai lai buy GenB

Posted by Michael_chan2022 > 1 month ago | Report Abuse

You could also ride the upward trend and sell your Genting shares at 10.., then switch over to Maybank
Lai...lai buy GenB

Posted by keyman > 1 month ago | Report Abuse

Confirmed everyone on board.... Any newcomers.... @Sifu michael your promotion is not enough... Cant attracts New bie.... You have to say... Lelong... Lelong.... Genting.... Buy3 free 1.....buy4 free 3....if not satisfy, 100% refundable... 🤭

Posted by Michael_chan2022 > 1 month ago | Report Abuse

Why lelong? We must have confidence in GenB... just as bank promoters promote the banking stocks

Posted by choysun > 1 month ago | Report Abuse

Buy 3 free 1? Bonus issue ah? :p

Posted by cactus81 > 1 month ago | Report Abuse

IPO US$ 15b. What is the price after listing? US$ 20? Just need to wait for six to twelve months.

Posted by Michael_chan2022 > 1 month ago | Report Abuse

Last week, traders were calling for a sell at RM5.., but now all remain silent. It's holding steadily above 5 now.

Guess the closing price today..

Posted by Michael_chan2022 > 1 month ago | Report Abuse

I anticipate it will close above 5.10 hari ini..

Posted by Michael_chan2022 > 1 month ago | Report Abuse

Make some noise... to infer the sentiment here

Posted by Michael_chan2022 > 1 month ago | Report Abuse

Bagus, the traders have all left

Posted by keyman > 1 month ago | Report Abuse

Need some $to Cheers us up... No $ no mood...